Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ankyrin repeat domain-containing protein 60 is a human protein encoded by the ANKRD60 gene, located on chromosome 20. The protein contains multiple ankyrin repeats, which are structural motifs known for mediating protein-protein interactions. Very limited functional characterization is available specifically for ANKRD60, but as with other ankyrin repeat domain proteins, it may play roles in cellular organization, intracellular signaling, or scaffolding. There is no strong evidence indicating ANKRD60 is a therapeutic target, nor is it classified as a receptor, enzyme, transporter, or transcription factor. The ANKRD60 gene has been associated genetically with intellectual developmental disorder, autosomal dominant, but there is no clear evidence implicating this protein directly in other disease mechanisms. No known interacting drugs, mechanisms of action, biomarker applications, or notable safety concerns have been reported for this molecule.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ankyrin repeat domain-containing protein 60 (ANKRD60).